Alector, Inc. (ALEC)
NASDAQ: ALEC · Real-Time Price · USD
2.390
+0.040 (1.70%)
At close: Apr 28, 2026, 4:00 PM EDT
2.390
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:04 PM EDT
Alector Employees
Alector had 103 employees as of December 31, 2025. The number of employees decreased by 135 or -56.72% compared to the previous year.
Employees
103
Change (1Y)
-135
Growth (1Y)
-56.72%
Revenue / Employee
$204,320
Profits / Employee
-$1,387,660
Market Cap
263.77M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Coherus Oncology | 147 |
| AC Immune | 122 |
| Zentalis Pharmaceuticals | 106 |
| Artiva Biotherapeutics | 104 |
| C4 Therapeutics | 104 |
| Editas Medicine | 87 |
| Cybin | 50 |
ALEC News
- 2 months ago - Alector Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Alector Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Alector to Participate in the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 4 months ago - Alector Appoints Neil Berkley as Chief Financial Officer and Chief Business Officer - GlobeNewsWire
- 5 months ago - Alector Transcript: BofA Securities CNS Therapeutics Virtual Conference 2025 - Transcripts
- 5 months ago - Alector to Participate in the Bank of America CNS Therapeutics Conference - GlobeNewsWire
- 5 months ago - ALEC Investors Have Opportunity to Join Alector, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewsWire
- 6 months ago - Alector Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire